Sutro Biopharma, Inc. (STRO) DCF Valuation

Sutro Biopharma, Inc. (STRO) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Sutro Biopharma, Inc. (STRO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (STRO) DCF Calculator enables you to evaluate Sutro Biopharma, Inc. valuation using real-world financial data while offering complete flexibility to modify all essential parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 42.7 42.7 61.9 67.8 153.7 213.0 295.2 409.2 567.0 785.8
Revenue Growth, % 0 -0.03275927 44.84 9.52 126.84 38.58 38.58 38.58 38.58 38.58
EBITDA -46.6 -23.8 -98.5 -105.1 -67.9 -170.3 -236.1 -327.1 -453.4 -628.3
EBITDA, % -109.08 -55.6 -159.22 -155.03 -44.18 -79.96 -79.96 -79.96 -79.96 -79.96
Depreciation 4.8 4.3 9.8 8.3 6.8 22.9 31.7 43.9 60.9 84.4
Depreciation, % 11.18 10.06 15.79 12.23 4.43 10.74 10.74 10.74 10.74 10.74
EBIT -51.4 -28.1 -108.3 -113.4 -74.7 -176.5 -244.6 -339.0 -469.8 -651.1
EBIT, % -120.26 -65.66 -175.01 -167.26 -48.61 -82.85 -82.85 -82.85 -82.85 -82.85
Total Cash 117.9 368.1 197.9 302.3 375.6 213.0 295.2 409.2 567.0 785.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 6.3 5.6 12.5 7.1 36.1
Account Receivables, % 14.74 13.01 20.13 10.51 23.47
Inventories .0 .0 .0 -11.7 .0 -7.3 -10.2 -14.1 -19.5 -27.1
Inventories, % 0 0 0.000001616031 -17.22 0 -3.44 -3.44 -3.44 -3.44 -3.44
Accounts Payable 5.6 5.5 6.0 4.8 9.4 20.9 28.9 40.1 55.5 77.0
Accounts Payable, % 13.07 12.98 9.71 7.08 6.14 9.79 9.79 9.79 9.79 9.79
Capital Expenditure -3.5 -7.1 -15.3 -7.9 -4.3 -27.3 -37.8 -52.4 -72.6 -100.6
Capital Expenditure, % -8.15 -16.69 -24.76 -11.59 -2.81 -12.8 -12.8 -12.8 -12.8 -12.8
Tax Rate, % -20.53 -20.53 -20.53 -20.53 -20.53 -20.53 -20.53 -20.53 -20.53 -20.53
EBITAT -51.4 -31.6 -111.5 -115.8 -90.1 -176.5 -244.6 -339.0 -469.8 -651.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -50.8 -33.7 -123.5 -99.6 -123.6 -160.9 -253.3 -351.0 -486.4 -674.1
WACC, % 23.81 23.81 23.81 23.81 23.81 23.81 23.81 23.81 23.81 23.81
PV UFCF
SUM PV UFCF -919.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -688
Terminal Value -3,153
Present Terminal Value -1,084
Enterprise Value -2,003
Net Debt -36
Equity Value -1,967
Diluted Shares Outstanding, MM 60
Equity Value Per Share -32.70

What You Will Get

  • Pre-Filled Financial Model: Sutro Biopharma’s actual data enables precise DCF valuation.
  • Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers.
  • Instant Calculations: Automatic updates ensure you see results as you make changes.
  • Investor-Ready Template: A refined Excel file designed for professional-grade valuation.
  • Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts.

Key Features

  • Comprehensive Data: Sutro Biopharma’s historical financial statements and detailed forecasts.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: View Sutro Biopharma’s intrinsic value recalculated instantly.
  • Visual Data Representation: Interactive dashboard charts illustrate valuation results and essential metrics.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the ready-to-use Excel file featuring Sutro Biopharma, Inc.'s (STRO) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and compare results instantly.
  • Make Decisions: Leverage the valuation outcomes to inform your investment strategy.

Why Choose This Calculator for Sutro Biopharma, Inc. (STRO)?

  • Designed for Industry Experts: A sophisticated tool utilized by researchers, financial analysts, and biopharma executives.
  • Comprehensive Data: Historical and projected financials for Sutro Biopharma preloaded for precision.
  • Flexible Scenario Analysis: Easily simulate various forecasts and assumptions for informed decision-making.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and other critical metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth and straightforward experience.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment related to Sutro Biopharma, Inc. (STRO).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
  • Consultants and Advisors: Deliver precise valuation analyses and insights for clients interested in Sutro Biopharma, Inc. (STRO).
  • Students and Educators: Leverage real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotechnology firms like Sutro Biopharma, Inc. (STRO) are valued in the investment landscape.

What the Template Contains

  • Pre-Filled Data: Includes Sutro Biopharma, Inc.'s (STRO) historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Sutro Biopharma, Inc.'s (STRO) profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.